UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002183
Receipt number R000002679
Scientific Title A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)
Date of disclosure of the study information 2009/07/10
Last modified on 2013/01/10 20:35:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)

Acronym

A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)

Scientific Title

A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)

Scientific Title:Acronym

A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)

Region

Japan


Condition

Condition

advanced/recurrent gastric cancer

Classification by specialty

Gastroenterology Hematology and clinical oncology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

A regimen of TS-1+CDDP plus PTX for outpatients with advanced /recurrent
gastric cancer is to be studied on the effectiveness and safety.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Response rate

Key secondary outcomes

overall survival(OS),progression free survival, and Incidence of adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Treatment Methd
CDDP 30mg/m2:day 1, day15,
PTX 70mg/m2:day 1, day15,
TS-1 80/mgm2:day1 – 21(on), day22 – 35(off)
A 5 weeks is the one course

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) diagnosed histologicaly and/or cytologicaly
(2) with measurable lesions
(3) without any prior therapy except patients who have received other Chemotherapies than CDDP, PTX or TS-1 before 4 weeks of this Study
(4) with normal organ functions
1) Hb <= 8.0g/dL
2) WBC:4,000-12000/mm3
3) Neutro: <=2000/mm3
4) Platelet: <=10x104/mm3
5) T.bil: >=1.5mg/dL
6) AST/ALT: <100 IU/L or <150 IU/L in patients with liver

Metastasis
7) sCr <= 1.2mg/dL1.
8) CCr >= 60mL/min in Cockcroft-Gault method
(5) PS 0-2
(6) longer than 3 months of the expected survival period
(7) age between 20 and 75 years old
(8) patients who can take orally
(9) with written informed consent

Key exclusion criteria

(1) with bleeding from digestive tract
(2) patients who cannot take orally due to some stenosis on digestive tract
(3) past history of severe allergy against some medicines
(4) with high volume of ascites and/or thoratic fluid
(5) with severe diseases (infection, interstitial pneumonitis, pulmonary fibrosis, cardiac failure, renal failure, liver disease, uncontrollable DM)
(6) with liver cirrhosis and/or jaundice
(7) with psychologic disorder which needs medicines
(8) with brain disorder due to brain metastasis
(9) with active second cancers.
(10) women under pregnancy or women expecting future birth
(11) doctors decision not to register to this trial

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kimura Yutaka

Organization

NTT West Japan Hospital

Division name

Dpt.Surgery

Zip code


Address

543-8922 2-6-40Karasugatuji Tennnouji-Ku Osaka

TEL

06-6773-7111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Furukawa

Organization

Kinki University Faculty of Medicen

Division name

Department of surgery

Zip code


Address

377-2, Onohigashi, Osakasayama, Osaka, Japan

TEL

072-366-0221

Homepage URL


Email



Sponsor or person

Institute

OGSG

Institute

Department

Personal name



Funding Source

Organization

NPO Osaka Chinical Study Supporting Organization

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 05 Month 13 Day

Date of IRB


Anticipated trial start date

2009 Year 05 Month 01 Day

Last follow-up date

2012 Year 05 Month 21 Day

Date of closure to data entry

2012 Year 12 Month 01 Day

Date trial data considered complete


Date analysis concluded

2012 Year 11 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 07 Month 10 Day

Last modified on

2013 Year 01 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002679


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name